News
The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback